◆英語タイトル:TearLab Corp (TEAR) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010024
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月26日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolarity system is a CE marked and the US FDA cleared device. The company conducts it research and development activities through its wholly-owned subsidiary, TearLab Research, Inc. The company sells its products directly in the US, Canada and the UK and through distributors in Europe, South America and Asia. TearLab is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company TearLab Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
TearLab Corp Company Overview 4
TearLab Corp Company Snapshot 4
TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview 4
TearLab Corp – Pipeline Analysis Overview 6
Business Description 6
TearLab Corp – Key Facts 6
TearLab Corp – Major Products and Services 7
TearLab Corp Pipeline Products by Development Stage 8
TearLab Corp Pipeline Products Overview 10
Multiplex Test Card 10
Multiplex Test Card Product Overview 10
Next Generation TearLab Osmolarity System 11
Next Generation TearLab Osmolarity System Product Overview 11
TearLab Discovery System 12
TearLab Discovery System Product Overview 12
TearLab Osmolarity System 13
TearLab Osmolarity System Product Overview 13
TearLab Corp – Key Competitors 14
TearLab Corp – Key Employees 15
TearLab Corp – Key Employee Biographies 16
TearLab Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
TearLab Corp, Recent Developments 18
Nov 13, 2017: TearLab Reports Third Quarter and September Year-To-Date 2017 Financial Results 18
Oct 17, 2017: TearLab Corporation Provides Update on U.S. Regulatory Strategy for TearLab Discovery System 18
Sep 27, 2017: TearLab Announces Release of 2018 – 2020 Preliminary Reimbursement Rates 19
Aug 14, 2017: TearLab Reports Second Quarter and First Half 2017 Financial Results 19
Jul 21, 2017: TearLab Announces European Regulatory Clearance for Next-Generation TearLab DiscoverySystem 20
May 15, 2017: TearLab Corporation Reports First Quarter 2017 Financial Results 21
May 12, 2017: TearLab Osmolarity System Receives Brazilian Regulatory Approval 21
Mar 09, 2017: TearLab Corporation Reports Fourth Quarter and Year End 2016 22
Mar 06, 2017: TearLab Announces CE Marking for Next-Generation System 22
Feb 13, 2017: TearLab Provides Update on International Market Milestones 23
Appendix 24
Methodology 24
About GlobalData 26
Contact Us 26
Disclaimer 27
List of Tables
TearLab Corp Pipeline Products and Ongoing Clinical Trials Overview 4
TearLab Corp Pipeline Products by Equipment Type 4
TearLab Corp Pipeline Products by Indication 5
TearLab Corp, Key Facts 6
TearLab Corp, Major Products and Services 7
TearLab Corp Number of Pipeline Products by Development Stage 8
TearLab Corp Pipeline Products Summary by Development Stage 9
Multiplex Test Card - Product Status 10
Multiplex Test Card - Product Description 10
Next Generation TearLab Osmolarity System - Product Status 11
Next Generation TearLab Osmolarity System - Product Description 11
TearLab Discovery System - Product Status 12
TearLab Discovery System - Product Description 12
TearLab Osmolarity System - Product Status 13
TearLab Osmolarity System - Product Description 13
TearLab Corp, Key Employees 15
TearLab Corp, Key Employee Biographies 16
TearLab Corp, Subsidiaries 17
Glossary 25